BridgeMD
New treatment option for Average Length of Stay
Official title Assessment of the Feasibility and Organisational Impact of a Care Pathway Incorporating the MultiSense® Medical Device for Post-operative Home Monitoring of Elderly Patients.
ClinicalTrials.gov ID: NCT07514286
What this study is testing
- What it's testing
- Assessing the clinical and organisational impact of a home-based post-operative monitoring strategy incorporating the MultiSense® device involving 80 patients aged 65 years and over who have undergone major surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Patient aged 65 or over
- Patient eligible for remote monitoring using the MultiSense® device
- No psychiatric illness that would prevent them from giving informed consent or receiving optimal treatment and follow-up care
- Subject affiliated with a health insurance scheme
- Subject able to read and understand English
You likely can't join if
- Patients already participating in an treatment clinical trial.
- Patients subject to legal protection measures, guardianship, curatorship, or deprived of their liberty by judicial or administrative decision.
- Patients hospitalised without consent.
- Patients unable to complete a questionnaire and without a close relative to assist them in using the solution.
- Patients admitted to or residing in a health or social care facility (other than for the surgery itself).
- Persons admitted to or residing in a health or social care institution (other than for the surgery itself);
See the full eligibility criteria
- Patient aged 65 or over
- Patient eligible for remote monitoring using the MultiSense® device
- No psychiatric illness that would prevent them from giving informed consent or receiving optimal treatment and follow-up care
- Subject affiliated with a health insurance scheme
- Subject able to read and understand English
- Subject who has signed an informed consent form
- people indicated for scheduled surgery
- Patients indicated for scheduled surgery :
- Transverse colectomy, by laparotomy
- Hepatic laparoscopy
- Laparoscopic or laparoscopic liver surgery (code hlfc or hlfa for procedures)
- Hysterectomy
- Adnexectomy
- Parietal surgery (eventration)
- Rectal resection
- Right and left colectomy
- Stoma closure by direct approach
- Patients already participating in an treatment clinical trial.
- Patients subject to legal protection measures, guardianship, curatorship, or deprived of their liberty by judicial or administrative decision.
- Patients hospitalised without consent.
- Patients unable to complete a questionnaire and without a close relative to assist them in using the solution.
- Patients admitted to or residing in a health or social care facility (other than for the surgery itself).
- Persons admitted to or residing in a health or social care institution (other than for the surgery itself);
- Persons unable to give their free and informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
- Bordeaux, France
- Mont-de-Marsan, France
- Nantes, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France; Bordeaux, France; Mont-de-Marsan, France; Nantes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.